Cargando…
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 compl...
Autores principales: | Moujaess, Elissar, Kourie, Hampig Raphael, Ghosn, Marwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174983/ https://www.ncbi.nlm.nih.gov/pubmed/32344317 http://dx.doi.org/10.1016/j.critrevonc.2020.102972 |
Ejemplares similares
-
Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?
por: Moujaess, Elissar, et al.
Publicado: (2020) -
Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
por: Boutros, Marc, et al.
Publicado: (2021) -
The future of cancer research after COVID-19 pandemic: recession?
por: Kourie, Hampig Raphael, et al.
Publicado: (2020) -
Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey
por: Moujaess, Elissar, et al.
Publicado: (2021) -
Checkpoint inhibitors in gastrointestinal cancers: Expectations and reality
por: Kourie, Hampig Raphael, et al.
Publicado: (2017)